Journal
JOURNAL OF CELL BIOLOGY
Volume 189, Issue 1, Pages 143-U203Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200905158
Keywords
-
Categories
Funding
- National Institutes of Health (NIH) [1F31-NS056466, RO1NS056158, RO1GM44757]
- National Ataxia Foundation
- Bob Allison Ataxia Research Center
Ask authors/readers for more resources
Spinocerebellar ataxia type 5 (SCA5) is an autosomal dominant neurodegenerative disorder caused by mutations in the SPBTN2 gene encoding. beta-III-spectrin. To investigate the molecular basis of SCA5, we established a series of transgenic Drosophila models that express human. beta-III-spectrin or fly beta-spectrin proteins containing SCA5 mutations. Expression of the SCA5 mutant spectrin in the eye causes a progressive neurodegenerative phenotype, and expression in larval neurons results in posterior paralysis, reduced synaptic terminal growth, and axonal transport deficits. These phenotypes are genetically enhanced by both dynein and dynactin loss-of-function mutations. In summary, we demonstrate that SCA5 mutant spectrin causes adult-onset neuro-degeneration in the fly eye and disrupts fundamental intracellular transport processes that are likely to contribute to this progressive neurodegenerative disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available